Prepare for your visit

Harmohina Bagga

Ophthalmology · Phoenix, AZ · NPI 1306024104

One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.

What was reported

$1,696.87

in general payments reported to CMS, 2019-2025 · $515 in 2025

The $515 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).

Who reported paying

General payments only, top 6 by amount.

Abbvie INC. $435.62
New World Medical,INC. $273.59
Aerie Pharmaceuticals, INC. $177.36
Alcon Vision LLC $161.30
Sun Pharmaceutical Industries INC. $142.19
Sight Sciences, INC. $88.32

Drugs and devices associated with these payments

Durysta Kahook Dual Blade Streamline Ahmed Glaucoma Valve Clearpath Via360 Omni Surgical System Idose Rocklatan Xen Glaucoma Treatment System Oxervate Triesence

Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.

Questions you might ask

I saw Harmohina Bagga listed in the CMS Open Payments database. Can you tell me about your work with those companies?
Is there a generic or alternative to this medication, and would it work as well for me?
What made you choose this particular treatment for my situation?

These are normal questions. A good clinician will welcome them.

Notes

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.

GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/104589/harmohina-bagga